Abstract
Although substantial progress has been made in understanding the molecular and pathological bases of neurodegeneration, there have been few successes in the clinic and a number of fundamental questions remain unanswered. Is this skepticism misplaced, or do the words of Sir Isaac Newton hold true, that “what we know is a drop, what we don't know is an ocean”?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission
Scientific Reports Open Access 02 September 2021
-
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Alzheimer's Research & Therapy Open Access 09 July 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Haass, C. EMBO J. 23, 483–488 (2004).
Rubinsztein, D.C. Nature 443, 780–786 (2006).
Veeraraghavalu, K., Choi, S.H., Zhang, X. & Sisodia, S.S. J. Neurosci. 30, 6903–6915 (2010).
Hu, X. et al. Nat. Neurosci. 9, 1520–1525 (2006).
Willem, M. et al. Science 314, 664–666 (2006).
Bremer, J. et al. Nat. Neurosci. 13, 310–318 (2010).
Brown, M.S., Ye, J., Rawson, R.B. & Goldstein, J.L. Cell 100, 391–398 (2000).
Aguzzi, A. & Haass, C. Science 302, 814–818 (2003).
Falsig, J. et al. Nat. Neurosci. 11, 109–117 (2008).
Hardy, J. & Selkoe, D.J. Science 297, 353–356 (2002).
Iacono, D. et al. Neurology 73, 665–673 (2009).
Holmes, C. et al. Lancet 372, 216–223 (2008).
Schenk, D. et al. Nature 400, 173–177 (1999).
Schenk, D., Hagen, M. & Seubert, P. Curr. Opin. Immunol. 16, 599–606 (2004).
Haass, C. & Selkoe, D.J. Nat. Rev. Mol. Cell Biol. 8, 101–112 (2007).
Walsh, D.M. et al. Nature 416, 535–539 (2002).
Podlisny, M.B. et al. Biochemistry 37, 3602–3611 (1998).
Lesné, S. et al. Nature 440, 352–357 (2006).
Shankar, G.M. et al. Nat. Med. 14, 837–842 (2008).
Laurén, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M. Nature 457, 1128–1132 (2009).
Calella, A.M. et al. EMBO Mol. Med. 2, 306–314 (2010).
Gimbel, D.A. et al. J. Neurosci. 30, 6367–6374 (2010).
Roberson, E.D. et al. Science 316, 750–754 (2007).
Ittner, L.M. et al. Cell 142, 387–397 (2010).
Ballatore, C., Lee, V.M. & Trojanowski, J.Q. Nat. Rev. Neurosci. 8, 663–672 (2007).
de Calignon, A. et al. Nature 464, 1201–1204 (2010).
Paquet, D. et al. J. Clin. Invest. 119, 1382–1395 (2009).
Meyer-Luehmann, M. et al. Science 313, 1781–1784 (2006).
Frost, B., Jacks, R.L. & Diamond, M.I. J. Biol. Chem. 284, 12845–12852 (2009).
Clavaguera, F. et al. Nat. Cell Biol. 11, 909–913 (2009).
Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B. & Olanow, C.W. Nat. Med. 14, 504–506 (2008).
Li, J.Y. et al. Nat. Med. 14, 501–503 (2008).
Aguzzi, A. & Rajendran, L. Neuron 64, 783–790 (2009).
Aguzzi, A. Nature 459, 924–925 (2009).
Chesebro, B. et al. Science 308, 1435–1439 (2005).
Thal, D.R., Capetillo-Zarate, E., Del Tredici, K. & Braak, H. Sci. SAGE KE 2006, re1 (2006).
Fraering, P.C. et al. Biochemistry 43, 9774–9789 (2004).
Bard, F. et al. Nat. Med. 6, 916–919 (2000).
Winklhofer, K.F., Tatzelt, J. & Haass, C. EMBO J. 27, 336–349 (2008).
Keller, J.N., Hanni, K.B. & Markesbery, W.R. J. Neurochem. 75, 436–439 (2000).
Ravikumar, B., Duden, R. & Rubinsztein, D.C. Hum. Mol. Genet. 11, 1107–1117 (2002).
Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A. & Nixon, R.A. J. Neurosci. 16, 186–199 (1996).
Lee, J.H. et al. Cell 141, 1146–1158 (2010).
Baker, M. et al. Nature 442, 916–919 (2006).
Cruts, M. et al. Nature 442, 920–924 (2006).
Rohrer, J.D. et al. Neuroimage published online, 10.1016/j.neuroimage.2009.12.088 (4 January 2010).
Dormann, D. et al. EMBO J. 29, 2841–2857 (2010).
Kwiatkowski, T.J. Jr. et al. Science 323, 1205–1208 (2009).
Vance, C. et al. Science 323, 1208–1211 (2009).
Di Monte, D.A., Lavasani, M. & Manning-Bog, A.B. Neurotoxicology 23, 487–502 (2002).
Lazarov, O. et al. Cell 120, 701–713 (2005).
Kang, J.E. et al. Science 326, 1005–1007 (2009).
Acknowledgements
This article reports on some of the main points raised at the Herrenhausen Symposium on Neurodegeneration in Seeon, Germany (May 2010) during the session on the initiation and propagation of neurodegeneration. I thank A. Aguzzi, D. Rubinsztein, S. Sisodia, D. Edbauer and M. Meyer-Lühmann for reading this manuscript. This work was supported by the Deutsche Forschungsgemeinschaft.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Haass, C. Initiation and propagation of neurodegeneration. Nat Med 16, 1201–1204 (2010). https://doi.org/10.1038/nm.2223
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2223
This article is cited by
-
Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission
Scientific Reports (2021)
-
Endocrinologia geriatrica, neuroimaging e imputabilità: disegnando l’aging del futuro
L'Endocrinologo (2018)
-
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
Alzheimer's Research & Therapy (2014)
-
Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
Molecular Neurobiology (2012)
-
Neuroprotectin D1 Induces Neuronal Survival and Downregulation of Amyloidogenic Processing in Alzheimer’s Disease Cellular Models
Molecular Neurobiology (2011)